Kamran Alam

Insider Reports History

Location
New York, NY
Signature
/s/ Kamran Alam, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kamran Alam:

Company Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. CHIEF FINANCIAL OFFICER Common Stock 1,546,603 $8,506,316 $5.50 12 Jan 2026 Direct
Taysha Gene Therapies, Inc. CHIEF FINANCIAL OFFICER Employee Stock Option (right to buy) 231,000 12 Jan 2026 Direct

Insider Reports Filed by Kamran Alam

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TSHA Taysha Gene Therapies, Inc. 12 Jan 2026 2 $0 4 CHIEF FINANCIAL OFFICER 14 Jan 2026, 16:45
TSHA Taysha Gene Therapies, Inc. 21 Aug 2025 1 -$155,299 4 CHIEF FINANCIAL OFFICER 22 Aug 2025, 16:15
TSHA Taysha Gene Therapies, Inc. 11 Mar 2025 1 -$50,435 4 CHIEF FINANCIAL OFFICER 13 Mar 2025, 16:15
TSHA Taysha Gene Therapies, Inc. 02 Jan 2025 2 $0 4 CHIEF FINANCIAL OFFICER 03 Jan 2025, 17:31
TSHA Taysha Gene Therapies, Inc. 02 Feb 2024 1 -$1,945 4 CHIEF FINANCIAL OFFICER 06 Feb 2024, 16:42
TSHA Taysha Gene Therapies, Inc. 02 Jan 2024 2 $0 4 Chief Financial Officer 04 Jan 2024, 16:43
TSHA Taysha Gene Therapies, Inc. 14 Dec 2023 1 $0 4 Chief Financial Officer 18 Dec 2023, 16:50
TSHA Taysha Gene Therapies, Inc. 24 Aug 2023 1 -$76,890 4 Chief Financial Officer 25 Aug 2023, 17:30
TSHA Taysha Gene Therapies, Inc. 31 May 2023 1 $0 4/A CHIEF FINANCIAL OFFICER 10 Apr 2025, 16:15
TSHA Taysha Gene Therapies, Inc. 02 Feb 2023 3 $0 4 Chief Financial Officer 06 Feb 2023, 20:12
TSHA Taysha Gene Therapies, Inc. 23 Aug 2022 1 -$11,538 4 Chief Financial Officer 24 Aug 2022, 16:47
TSHA Taysha Gene Therapies, Inc. 18 Aug 2022 3 -$105,999 4 Chief Financial Officer 22 Aug 2022, 20:05
TSHA Taysha Gene Therapies, Inc. 06 Apr 2022 1 $0 4 Chief Financial Officer 08 Apr 2022, 16:27
TSHA Taysha Gene Therapies, Inc. 23 Feb 2022 1 $0 4 Chief Financial Officer 25 Feb 2022, 15:18
TSHA Taysha Gene Therapies, Inc. 18 Aug 2021 5 -$557,023 4 Chief Financial Officer 20 Aug 2021, 17:52